Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals

PLoS Pathogens

Volumn 10, Issue 8, 2014, Pages

  Klatt, Nichole R ^a,b   Bosinger, Steven E ^c   Peck, Melicent ^d   Richert Spuhler, Laura E ^a   Heigele, Anke ^e   Gile, Jillian P ^a   Patel, Nirav ^c   Taaffe, Jessica ^c   Julg, Boris ^f   Camerini, David ^g   Torti, Carlo ^h   Martin, Jeffrey N ^d   Deeks, Steven G ^d   Sinclair, Elizabeth ^d   Hecht, Frederick M ^d   Lederman, Michael M ⁱ   Paiardini, Mirko ^c   Kirchhoff, Frank ^e   Brenchley, Jason M ^b   Hunt, Peter W ^d   Silvestri, Guido ^c   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF BRESCIA   (Italy)

ⁱ UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CENTRAL MEMORY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STEM CELL MEMORY; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS LOAD; YOUNG ADULT; CELL SEPARATION; DNA MICROARRAY; IMMUNOLOGY; STEM CELL; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

VIRUS DNA;

CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DISEASE PROGRESSION; DNA, VIRAL; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STEM CELLS; T-LYMPHOCYTE SUBSETS; VIRAL LOAD; VIREMIA;

EID: 84911432282     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004345     Document Type: Article

References (47)

1. Deeks SG, Walker BD, (2007) Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy. Immunity 27: 406–416.
2. Sodora DL, Silvestri G, (2008) Immune activation and AIDS pathogenesis. AIDS 22: 439–446.
3. Paiardini M, Cervasi B, Dunham R, Sumpter B, Radziewicz H, et al. (2004) Cell-cycle dysregulation in the immunopathogenesis of AIDS. Immunol Res 29: 253–268.
4. Cohen OJ, Kinter A, Fauci AS, (1997) Host factors in the pathogenesis of HIV disease. Immunol Rev 159: 31–48.
5. Casado C, Colombo S, Rauch A, Martinez R, Gunthard HF, et al. (2010) Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS One 5: e11079.
6. Cao Y, Qin L, Zhang L, Safrit J, Ho DD, (1995) Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection. N Engl J Med 332: 201–208.
7. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, et al. (1996) Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses 12: 585–592.
8. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, et al. (1995) Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332: 209–216.
9. Descours B, Avettand-Fenoel V, Blanc C, Samri A, Melard A, et al. (2012) Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin Infect Dis 54: 1495–1503.
10. Migueles SA, Connors M, (2010) Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA 304: 194–201.
11. Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, et al. (2007) Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J Virol 81: 13904–13915.
12. Elrefaei M, McElroy MD, Preas CP, Hoh R, Deeks S, et al. (2004) Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol 173: 2184–2189.
13. Klatt NR, Silvestri G, (2012) CD4+ T Cells and HIV: A Paradoxical Pas de Deux. Science Translational Medicine 4: 123ps124.
14. Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, et al. (2011) Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 121: 2391–2400.
15. Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, et al. (2007) Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 81: 8838–8842.
16. Curriu M, Fausther-Bovendo H, Pernas Ma, Massanella M, Carrillo J, et al. (2012) Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function. PLoS One 7: e30330.
17. Ballana E, Ruiz-de Andres A, Mothe B, Ramirez de Arellano E, Aguilar F, et al. (2012) Differential prevalence of the HLA-C – 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals. Immunobiology 217: 889–894.
18. Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, et al. (2013) Short communication: HIV(+) viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses 29: 172–177.
19. Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, et al. (2010) Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 6: e1000917.
20. Klatt NR, Silvestri G, Hirsch V, (2012) Nonpathogenic simian immunodeficiency virus infections. Cold Spring Harb Perspect Med 2: a007153.
21. Klatt NR, Chomont N, Douek DC, Deeks SG, (2013) Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev 254: 326–342.
22. Buzon MJ, Sun H, Li C, Shaw A, Seiss K, et al. (2014) HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med 20: 139–142.
23. Lugli E, Dominguez MH, Gattinoni L, Chattopadhyay PK, Bolton DL, et al. (2013) Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest 123: 594–599.
24. Cartwright EK, McGary CS, Cervasi B, Micci L, Lawson B, et al. (2014) Divergent CD4+ T Memory Stem Cell Dynamics in Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections. J Immunol 192: 4666–4673.
25. Paiardini M, Cervasi B, Reyes-Aviles E, Micci L, Ortiz AM, et al. (2011) Low levels of SIV infection in sooty mangabey central memory CD(4)(+) T cells are associated with limited CCR5 expression. Nat Med 17: 830–836.
26. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, et al. (2002) Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16: 1119–1129.
27. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859–870.
28. Brenchley JM, Hill BJ, Ambrozak DR, Price DA, Guenaga FJ, et al. (2004) T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 78: 1160–1168.
29. Patel VP, Kreider BL, Li Y, Li H, Leung K, et al. (1997) Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 185: 1163–1172.
30. Lee YS, Won KJ, Park SW, Lee HW, Kim B, et al. (2012) Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2. Cell Immunol 279: 1–11.
31. Schreiber TH, Podack ER, (2013) Immunobiology of TNFSF15 and TNFRSF25. Immunol Res 57: 3–11.
32. Jin J, Yu Q, Han C, Hu X, Xu S, et al. (2013) LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition. Nat Commun 4: 2075.
33. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.
34. Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, et al. (2009) Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 200: 973–983.
35. Lichtfuss GF, Hoy J, Rajasuriar R, Kramski M, Crowe SM, et al. (2011) Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection. Biomark Med 5: 171–186.
36. Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G, (2012) Natural SIV hosts: showing AIDS the door. Science 335: 1188–1193.
37. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, et al. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15: 893–900.
38. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95–98.
39. Groves KC, Bibby DF, Clark DA, Isaksen A, Deayton JR, et al. (2012) Disease Progression in HIV-1-Infected Viremic Controllers. J Acquir Immune Defic Syndr 61: 407–416.
40. McGary CS, Cervasi B, Chahroudi A, Micci L, Taaffe J, et al. (2014) Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques. J Virol 88: 4533–4542.
41. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, et al. (2006) Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055–1067.
42. Okoye A, Meier-Schellersheim M, Brenchley JM, Hagen SI, Walker JM, et al. (2007) Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204: 2171–2185.
43. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, et al. (1998) New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280: 42–48.
44. Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, et al. (2003) Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 33: 625–634.
45. Hatano H, Vivek Jain V, Hunt P, Lee T, Sinclair H, et al. (2013) Cell-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1 Expressing CD4+ T cells. J Infect Dis 208: 50–56.
46. Klatt NR, Vinton CL, Lynch RM, Canary LA, Ho J, et al. (2011) SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. Blood 118: 5803–5812.
47. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, et al. (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. The Journal of Clinical Investigation 119: 3556–3572.